Implant Placement in Mandibular Molar Xenograft Versus PRF
Launched by CAIRO UNIVERSITY · Jun 5, 2017
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with non-restorable mandibular molars
- • 2. Both sexes
- • -
- Exclusion Criteria:
- • • Heavy smokers more than 20 cigarettes per day.5
- • Patients with in sufficient interseptal bone height and width
- • Patients with systemic disease that may affect normal healing.
- • Patients with completely resorbed buccal cortical plate.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials